I recently wrote a print feature for Men's Health about creatine's remarkable transformation from controversial supplement to mainstream wellness product, focusing particularly on its current momentum as a cognitive enhancer. That piece tracks how creatine has evolved from a niche bodybuilding supplement into something you might find at Target, fueled by influencers like Andrew Huberman and companies marketing it for brain health. But due to space constraints and editorial focus on the contemporary moment, we had to leave out crucial chapters of the supplement's fascinating origin story — most notably the role of Anthony Almada, the UC Berkeley-educated biochemist who, along with his partner Ed Byrd, first brought creatine monohydrate to market through their company EAS in 1993.
Read Full Article »
